Cancer immunotherapy: advancing and accelerating immuno-oncology research and development
Cancer immunotherapy has emerged as an exciting new approach to cancer treatment because of its specificity, adaptability and durability. The discovery of immune targets and development of therapeutic antibodies against immune checkpoints is becoming the momentum among academia and pharmaceutical industry. With the increasing success and subsequent interests in cancer immunotherapy, there is a growing need for well-characterized cell models, antibodies and proteins for immune-oncology. If you are interested in this rising field, or want to advance and accelerate your immune-oncology research, please join this webinar. We will introduce the development, application and challenges in Cancer immunotherapy field, and the one-stop station including diversity functional antibodies, targets, cell models and assay platforms from GenScript to accelerate the related discovery and development program.
|Cancer immunotherapy: advancing and accelerating immuno-oncology research and development|
|Immune Checkpoint Stable Cell Lines||Immune Checkpoint Antibodies||Immune checkpoint proteins|